Novel AI boosts breast cancer detection in mammograms

The MASAI trial reveals AI in mammography increases cancer detection by 29% and decreases radiologists’ workload by 44%, ensuring diagnostic reliability.

Opinion | It’s High Time for Gender-Inclusive Clinical Research

Kim and Wilson are medical students. White men have historically been valued as primary subjects of consensual medical research, therefore harming racial minorities, women, the

July 19, 2023

Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 25.07.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

July 26, 2024

Opinion | Federal Probes Need to Look Beyond Private Equity-Owned Healthcare for Alleged Abuse

Ron Harman King is CEO of Vanguard Communications, a healthcare marketing and practice management consulting firm, and author of “The Totally Wired Doctor: Social Media,

April 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.